Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - CA2208741017 - Common Stock

0.09 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CJR-B. CJR-B was compared to 12 industry peers in the Media industry. There are concerns on the financial health of CJR-B while its profitability can be described as average. CJR-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CJR-B has reported negative net income.
In the past year CJR-B had a positive cash flow from operations.
In the past 5 years CJR-B reported 4 times negative net income.
In the past 5 years CJR-B always reported a positive cash flow from operatings.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of -4.53%, CJR-B perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.78%, CJR-B is doing good in the industry, outperforming 72.73% of the companies in the same industry.
CJR-B had an Average Return On Invested Capital over the past 3 years of 8.40%. This is in line with the industry average of 6.45%.
Industry RankSector Rank
ROA -4.53%
ROE N/A
ROIC 6.78%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

The Operating Margin of CJR-B (9.73%) is better than 81.82% of its industry peers.
CJR-B's Operating Margin has declined in the last couple of years.
CJR-B's Gross Margin of 54.00% is amongst the best of the industry. CJR-B outperforms 81.82% of its industry peers.
In the last couple of years the Gross Margin of CJR-B has declined.
Industry RankSector Rank
OM 9.73%
PM (TTM) N/A
GM 54%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1

2. Health

2.1 Basic Checks

CJR-B has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CJR-B remains at a similar level compared to 1 year ago.
CJR-B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CJR-B has a worse debt to assets ratio.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CJR-B has an Altman-Z score of -1.53. This is a bad value and indicates that CJR-B is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.53, CJR-B is in line with its industry, outperforming 45.45% of the companies in the same industry.
CJR-B has a debt to FCF ratio of 31.40. This is a negative value and a sign of low solvency as CJR-B would need 31.40 years to pay back of all of its debts.
CJR-B has a worse Debt to FCF ratio (31.40) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 31.4
Altman-Z -1.53
ROIC/WACC1.64
WACC4.13%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CJR-B has a Current Ratio of 0.73. This is a bad value and indicates that CJR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CJR-B has a Current ratio of 0.73. This is in the lower half of the industry: CJR-B underperforms 63.64% of its industry peers.
A Quick Ratio of 0.73 indicates that CJR-B may have some problems paying its short term obligations.
CJR-B has a worse Quick ratio (0.73) than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

0

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -200.00% in the last year.
The earnings per share for CJR-B have been decreasing by -43.12% on average. This is quite bad
CJR-B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.09%.
The Revenue has been decreasing by -5.52% on average over the past years.
EPS 1Y (TTM)-200%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%160%
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-10.25%

3.2 Future

The Earnings Per Share is expected to decrease by -69.66% on average over the next years. This is quite bad
CJR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.76% yearly.
EPS Next Y-412.44%
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%
EPS Next 5YN/A
Revenue Next Year-12%
Revenue Next 2Y-9.59%
Revenue Next 3Y-7.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

CJR-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CJR-B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

CJR-B's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CJR-B is cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CJR-B is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.51
EV/EBITDA 1.44
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

CJR-B's earnings are expected to decrease with -69.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%

0

5. Dividend

5.1 Amount

CJR-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (8/29/2025, 7:00:00 PM)

0.09

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)06-26 2025-06-26/bmo
Earnings (Next)10-23 2025-10-23/amc
Inst Owners1.42%
Inst Owner ChangeN/A
Ins Owners3.6%
Ins Owner ChangeN/A
Market Cap17.65M
Analysts43.08
Price Target0.07 (-22.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)70.37%
Min EPS beat(2)-75.76%
Max EPS beat(2)216.51%
EPS beat(4)3
Avg EPS beat(4)61.36%
Min EPS beat(4)-75.76%
Max EPS beat(4)216.51%
EPS beat(8)5
Avg EPS beat(8)11.57%
EPS beat(12)6
Avg EPS beat(12)-150.88%
EPS beat(16)8
Avg EPS beat(16)-114.76%
Revenue beat(2)0
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)-2.93%
Revenue beat(4)0
Avg Revenue beat(4)-4.34%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-2.93%
Revenue beat(8)0
Avg Revenue beat(8)-4.09%
Revenue beat(12)0
Avg Revenue beat(12)-4.01%
Revenue beat(16)1
Avg Revenue beat(16)-3.38%
PT rev (1m)-19.65%
PT rev (3m)-19.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.37%
EPS NY rev (1m)34.06%
EPS NY rev (3m)34.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.86%
Revenue NY rev (1m)-0.68%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.51
P/OCF 0.37
P/B N/A
P/tB N/A
EV/EBITDA 1.44
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.18
FCFY194.86%
OCF(TTM)0.24
OCFY267.04%
SpS5.94
BVpS-2.24
TBVpS-7.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.53%
ROE N/A
ROCE 9.42%
ROIC 6.78%
ROICexc 7.27%
ROICexgc 95.01%
OM 9.73%
PM (TTM) N/A
GM 54%
FCFM 2.95%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 31.4
Debt/EBITDA 1.53
Cap/Depr 2.16%
Cap/Sales 1.09%
Interest Coverage 1.57
Cash Conversion 6.7%
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z -1.53
F-Score5
WACC4.13%
ROIC/WACC1.64
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%160%
EPS Next Y-412.44%
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-10.25%
Revenue Next Year-12%
Revenue Next 2Y-9.59%
Revenue Next 3Y-7.76%
Revenue Next 5YN/A
EBIT growth 1Y-31.39%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year0.25%
EBIT Next 3Y6.51%
EBIT Next 5YN/A
FCF growth 1Y-72.11%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-66.62%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%